![美股開市前:非農弱於預期,降息50點概率過半!期金升破2550美元](https://i-invdn-com.investing.com/news/LYNXMPEB1Q0LH_S.jpg)
注冊以創建關於儀器的通知
你所追隨的作者的經濟活動和內容
免費註冊 已有帳戶? 登入
名稱 | 主旨 | 成立於 | 直至 |
---|---|---|---|
Morris Wu | Research Analyst | 2019 | now |
自傳 | Morris is a member of the Global Emerging Markets and Asia Pacific Equities team and is responsible for investment analysis of China/Hong Kong equities. Morris joined UBS Global Asset Management in May 2015. Prior to this, he was a consulting director at BDA China, providing investment advisory services to top tier hedge funds and private equity funds for their investments in China. Morris worked at BDA for 9 years and specialized in the Consumer and TMT sectors. | ||
Denise Cheung | - | 2018 | now |
Bin Shi | Portfolio Manager | 2013 | now |
自傳 | Bin Shi is a member of the Global Emerging Market and Asia Pacific Equities team, located in Hong Kong. He is Country Analyst and Portfolio Manager for China with a focus on Chinese stocks listed on both the overseas and domestic Chinese stock exchanges. Prior to joining UBS Asset Management, Bin spent three years as Head of Int’l Business, portfolio manager and analyst with Boshi Fund Management Co., one of the largest domestic mutual fund companies in China. Prior to that, he worked in the US for eight years as portfolio manager and analyst for several US mutual fund firms. Bin joined UBS in January 2006 and has managed the Greater China Fund since April 2006. | ||
Yu Zhang | - | 2018 | 2019 |
Derrick Sun | - | 2009 | 2018 |
自傳 | Derrick Sun is a member of the Global Emerging Markets and Asian Pacific Equities team and is responsible for investment analysis of China/Hong Kong Equities. Derrick joined UBS Asset Management in July 2013. Prior to this, he was head of research for healthcare and small & mid-cap with Bank of China International (BOCI) and BNP Paribas. Previous industry experience includes 5 years managing a bio-pharmaceutical company’s Shanghai subsidiary and 5 years in Deloitte Consulting (US) where he provided business consulting services to Fortune 500 healthcare and consumer companies. | ||
Projit Chatterjee | - | 2007 | 2018 |
自傳 | Projit Chatterjee is a Senior Equity Specialist within the Global Emerging Markets and Asia Pacific Equities team at UBS Asset Management, based in Singapore. He is also a member of the Global Emerging Markets Strategy Committee and co-manager of the GEM High Dividend funds. Projit has primary responsibility for overall product positioning and development of Emerging Markets and Asian Equity strategies, as well as marketing and communication of these strategies to existing and prospective clients globally. Projit joined UBS in 1997 as a Corporate Finance Analyst with UBS Investment Bank in Mumbai, India. In 1999, he moved to UBS Asset Management in Zurich to work in Strategic Projects, International Fund Marketing. In Zurich, Projit held various roles in the areas of strategic business development, business management and investment solutions. He also led an acquisition project in the Indian market. Before joining UBS, Projit worked as a money market and foreign exchange dealer in the treasury of MashreqBank, a UAE bank in Mumbai. |
你確定要封鎖 %USER_NAME%?
此舉將會令你與 %USER_NAME% 之間無法看見對方的Investing.com貼文。
%USER_NAME% 已成功加入你的封鎖清單
你剛解除此人的封鎖,必須等候 48 小時後才可再次封鎖。
我覺得這個評論是:
謝謝!
您的報告已被發送到我們的版主審核